AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $305,000 | -46.0% | 19,059 | -39.7% | 0.11% | +21.8% |
| Q1 2021 | $565,000 | +101.8% | 31,619 | +52.4% | 0.09% | +117.5% |
| Q4 2020 | $280,000 | -34.4% | 20,742 | +17.5% | 0.04% | -36.5% |
| Q4 2019 | $427,000 | +33.4% | 17,650 | +108.0% | 0.06% | -46.2% |
| Q3 2016 | $320,000 | – | 8,485 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LEVIN CAPITAL STRATEGIES, L.P. | 1,373,542 | $15,658,000 | 1.56% |
| DAFNA Capital Management LLC | 289,040 | $3,295,000 | 0.87% |
| Integral Health Asset Management, LLC | 250,000 | $2,850,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 193,266 | $2,203,000 | 0.80% |
| PFM Health Sciences, LP | 2,182,684 | $24,883,000 | 0.73% |
| DCF Advisers, LLC | 136,501 | $1,556,000 | 0.69% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,977,020 | $33,938,000 | 0.66% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $3,532,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 750,000 | $8,550,000 | 0.60% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,232,600 | $14,052,000 | 0.52% |